Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Yuflyma 20mg/0.2ml inj pre-filled syringes
1001030S0BHAEAF
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 40mg/0.4ml inj pre-filled syringes
1001030S0BHABAE
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 40mg/0.4ml solution for injection pre-filled pens
1001030S0BHAAAD
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 80mg/0.8ml inj pre-filled syringes
1001030S0BHADAG
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 80mg/0.8ml solution for injection pre-filled pens
1001030S0BHACAH
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.